Showing results (761-770 of 1,892) with videos related to
Sort By:
Pageof 190
Immunotherapy|May 4, 2016
A network meta-analysis of the risk of immune-related renal toxicity in cancer patients treated with immune checkpoint inhibitorsOmar Abdel-Rahman, Mona FouadImmunotherapy|March 15, 2016
Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?Sherise D Ferguson, Visish M Srinivasan, Michael Gz Ghali, et al.Immunotherapy|March 15, 2016
The antileukemic potential of natural killer cellsGiovanni F Torelli, Nadia Peragine, Paola Mariglia, et al.Immunotherapy|March 15, 2016
Mesothelin as a target for chimeric antigen receptor-modified T cells as anticancer therapyMark O'Hara, Caitlin Stashwick, Andrew R Haas, et al.Immunotherapy|March 15, 2016
Hepatitis B immunopathogenesis and immunotherapyForough Golsaz-Shirazi, Fazel ShokriImmunotherapy|March 15, 2016
The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysisPedro N Aguiar, Ilka Lopes Santoro, Hakaru Tadokoro, et al.Immunotherapy|September 4, 2020
Outcomes following immunotherapy re-challenge after immune-related adverse event: systematic review and meta-analysisRobin Park, Laercio Lopes, Anwaar SaeedImmunotherapy|November 23, 2020
Rechallenge of anti-PD-1/PD-L1 antibody showed a good response to metastatic breast cancer: a case reportYoko Otani, Kiyoshi Mori, Nozomi Morikawa, et al.Immunotherapy|November 23, 2020
Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysisFilippo Gustavo Dall'Olio, Alessandro Rizzo, Veronica Mollica, et al.Pageof 190